Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review

Hiroyoshi Takeuchi, Sadhana Thiyanavadivel, Gagan Fervaha, Gary Remington

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)274-276
Number of pages3
JournalJournal of clinical psychopharmacology
Issue number2
Publication statusPublished - 2017 Apr 1

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this